• Mechanism of Action
• Contains a long acting muscarinic agent (LAMA) as well as a long-acting beta 2 agonist (LABA), both of which are bronchodilators.

Clinical Use

• • Indication
  • Maintenance therapy for COPD.
• • Adverse Effects